Literature DB >> 25974663

ACR Appropriateness Criteria® Metastatic Epidural Spinal Cord Compression and Recurrent Spinal Metastasis.

Simon Shek-Man Lo1, Samuel Ryu2, Eric L Chang3, Nicholas Galanopoulos4, Joshua Jones5, Edward Y Kim6, Charlotte D Kubicky7, Charles P Lee8, Peter S Rose9, Arjun Sahgal10, Andrew E Sloan11, Bin S Teh12, Bryan J Traughber13, Catherine Van Poznak14, Andrew D Vassil15.   

Abstract

Metastatic epidural spinal cord compression (MESCC) is an oncologic emergency and if left untreated, permanent paralysis will ensue. The treatment of MESCC is governed by disease, patient, and treatment factors. Patient's preferences and goals of care are to be weighed into the treatment plan. Ideally, a patient with MESCC is evaluated by an interdisciplinary team promptly to determine the urgency of the clinical scenario. Treatment recommendations must take into consideration the risk-benefit profiles of surgical intervention and radiotherapy for the particular individual's circumstance, including neurologic status, performance status, extent of epidural disease, stability of the spine, extra-spinal disease status, and life expectancy. In patients with high spinal instability neoplastic score (SINS) or retropulsion of bone fragments in the spinal canal, surgical intervention should be strongly considered. The rate of development of motor deficits from spinal cord compression may be a prognostic factor for ultimate functional outcome, and should be taken into account when a treatment recommendation is made. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every three years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.

Entities:  

Mesh:

Year:  2015        PMID: 25974663     DOI: 10.1089/jpm.2015.28999.sml

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  10 in total

1.  Single fraction spine stereotactic ablative body radiotherapy with volumetric modulated arc therapy.

Authors:  Matthew M Gestaut; Nitika Thawani; Sangroh Kim; Veera R Gutti; Sameer Jhavar; Niloyjyoti Deb; Andrew Morrow; Russell A Ward; Jason H Huang; Mehul Patel
Journal:  J Neurooncol       Date:  2017-04-13       Impact factor: 4.130

2.  Modern approaches to the management of metastatic epidural spinal cord compression.

Authors:  Zain A Husain; Arjun Sahgal; Eric L Chang; Pejman Jabehdar Maralani; Charlotte D Kubicky; Kristin J Redmond; Charles Fisher; Ilya Laufer; Simon S Lo
Journal:  CNS Oncol       Date:  2017-07-18

3.  Frequency of Complicated Symptomatic Bone Metastasis Over a Breadth of Operational Definitions.

Authors:  Sara R Alcorn; Christen R Elledge; Jean L Wright; Thomas J Smith; Todd R McNutt; Jacob Fiksel; Scott L Zeger; Theodore L DeWeese
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-12-02       Impact factor: 7.038

Review 4.  Diagnosis and treatment of epidural metastases.

Authors:  S A Grossman; D Lossignol
Journal:  Oncology (Williston Park)       Date:  1990-04       Impact factor: 2.990

Review 5.  Stereotactic body radiotherapy for spinal metastases: a review.

Authors:  Lanlan Guo; Lixin Ke; Ziyi Zeng; Chuanping Yuan; Ziwei Wu; Lei Chen; Lixia Lu
Journal:  Med Oncol       Date:  2022-05-23       Impact factor: 3.064

6.  Composite PEEK/Carbon fiber implants can increase the effectiveness of radiotherapy in the management of spine tumors.

Authors:  Giuseppe Tedesco; Alessandro Gasbarrini; Stefano Bandiera; Riccardo Ghermandi; Stefano Boriani
Journal:  J Spine Surg       Date:  2017-09

Review 7.  Decision Making in Patients With Metastatic Spine. The Role of Minimally Invasive Treatment Modalities.

Authors:  Alfredo Conti; Güliz Acker; Anne Kluge; Franziska Loebel; Anita Kreimeier; Volker Budach; Peter Vajkoczy; Ilaria Ghetti; Antonino F Germano'; Carolin Senger
Journal:  Front Oncol       Date:  2019-09-19       Impact factor: 6.244

8.  Steroids in the Management of Preoperative Neurological Deficits in Metastatic Spine Disease: Results From the EPOSO Study.

Authors:  Anne L Versteeg; Lior M Elkaim; Arjun Sahgal; Laurence D Rhines; Daniel M Sciubba; James M Schuster; Michael G Fehlings; Aron Lazary; Michelle J Clarke; Paul M Arnold; Chetan Bettegowda; Stefano Boriani; Ziya L Gokaslan; Charles G Fisher; Michael H Weber
Journal:  Neurospine       Date:  2022-01-30

Review 9.  Diagnostic algorithm, prognostic factors and surgical treatment of metastatic cancer diseases of the long bones and spine.

Authors:  Miklós Szendrői; Imre Antal; Attila Szendrői; Áron Lazáry; Péter Pál Varga
Journal:  EFORT Open Rev       Date:  2017-09-01

10.  Spine Metastasis Practice Patterns among Korean, Chinese, and Japanese Radiation Oncologists: A Multinational Online Survey Study.

Authors:  Jeong Il Yu; Hee Chul Park; Yong Chan Ahn; Xian-Shu Gao; Jun-Jie Wang; Zhao-Chong Zeng; Yoshinori Ito; Tatsuya Ohno; Yasumasa Nishimura
Journal:  J Radiat Res       Date:  2016-09-26       Impact factor: 2.724

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.